Colossal (Series A)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$1,300,000,000,000

Company Info
Founders
Ben Lamm
Company Description
Colossal is combining the science of genetics with the business of discovery to build the world’s first de-extinction and species preservation company and more broadly advance economies of biology and healing through genetics. Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.
Market
Healthcare & Wellness
Coinvestors
At One Ventures, L.P.

Links